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  IODIMETRIC ASSAY OF OLANZAPINE IN 
PHARMACEUTICALS USING IODATE 
AND NILE BLUE AS REAGENTS 
A simple, selective and cost effective spectrophotometric method has been 
described for the determination of olanzapine (OLP) in bulk drug and in tablets. 
The method involves treating OLP with an excess of iodate in acid medium fol-
lowed by the determination of liberated iodine by reacting with a fixed amount 
of Nile blue and measuring the absorbance at 400 nm. In this method, the 
amount of iodine reacted corresponds to the OLP concentration. The experi-
mental conditions for the assay have been optimized and the absorbance is 
found to increase linearly with the concentration of OLP (r = 0.997). Beer’s law 
is obeyed over the range 15-120 µg mL
-1. The calculated molar absorptivity 
and Sandell sensitivity values are 0.657×10
3 l mol
-1 cm
-1 and 0.475 µg cm
-2, 
respectively. The limits of detection (LOD) and quantification (LOQ) are 3.93 
and 11.90 µg ml
-1. The performance of the method was validated according to 
the present ICH guidelines. The repeatability and intermediate precision, ex-
pressed by the RSD was better than 3%. The accuracy of the method ex-
pressed as relative error was satisfactory. The proposed method was applied 
to the analysis of tablet form of OLP and the results tallied well with the label 
claim. No interference was observed from concomitant substances normally 
added to tablets. The results were statistically compared with those of a lite-
rature method by applying the Student’s t-test and F-test. The accuracy and 
validity of the method were further ascertained by performing recovery studies 
via spike method. 
Key words: olanzapine; assay; spectrophotometry; iodate; pharmaceuti-
cals; Nile blue. 
 
 
Olanzapine (OLP), chemically known as 2-me-
thyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3b] [1,5] 
benzodiazepine (Fig 1), is an atypical antipsychotic 
drug used in the treatment of Schizophrenia and other 
psychotic syndromes [1]. Since its introduction in 
1996 in over 84 countries, several workers have re-
ported HPLC methods for the determination of OLP in 
human plasma, serum, urine, breast milk and rat brain 
[2-12]. HPLC has also been used for the assay of 
OLP in pharmaceutical formulations when present either 
alone [13,14] or in combination with fluoxetine [15,16]. 
Various other techniques including HPTLC [16], non- 
-aqueous titrimetry and UV-spectrophotometry [17], 
derivative spectrophotometry, capillary zone electro-
phoresis and linear voltammetry [13] have also been 
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reported for the assay of OLP in pharmaceuticals. Bi-
ryol and Erk [18] have applied voltametric, spectro-
photometric and HPLC techniques for the analysis of 
OLP. The reported HPLC methods [13,14] require ex-
pensive experimental set up and costly solvents be-
sides involving time-consuming start-up and clean-up 
procedures. In both the methods, the separation and 
detection is crucially dependant on the pH of the mo-
bile phase. Moreover, the method of Xuejun [14] is 
less sensitive with a linear range of 10-1000 µg ml
-1. 
The currently available voltammetric techniques [13,18] 
require sophisticated instrumentation and normally lack 
robustness and ruggedness because of the involve-
ment of scrupulous experimental conditions. The UV- 
-spectrophotometric methods reported by Firdous et 
al. [17] and Biryol and Erk [18] suffer from the dis-
advantage of interference from the inactive ingredi-
ents which absorb in the UV-region. Further, spectro-
photometry and voltametry [13] are reported to be less 
precise (RSD ≈ 3%) and less accurate (RE ≈ 2.6%). K. BASAVAIAH et al.: IODIMETRIC ASSAY OF OLANZAPINE…  CI&CEQ 15 (2) 95−102 (2009) 
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Fig. 1. Structure of olanzapine. 
In contrast, a visible spectrophotometry needs a 
simple and inexpensive instrumental set up and often 
provides high sensitivity, fair accuracy and precision 
and requires cheap and easily available chemicals. 
There are only three reports on the use of the visible 
spectrophotometry in the assay of OLP. Jasinska and 
Nalewajko [19] have developed one indirect and two 
direct flow-injection spectrophotometric methods using 
hexacyanoferrate (III) and cerium (IV) sulphate as re-
agents.  N-Bromosuccinimide (NBS) and cerium (IV) 
sulphate have been suggested as the oxidimetric re-
agents for the sensitive determination of OLP by di-
rect and indirect methods in conjunction with Celes-
tine blue [20]. Mohamed [21] has reported two kinetic 
spectrophotometric methods for the determination of 
OLP in its dosage forms and spiked serum samples. 
However, the reported methods suffer from such dis-
advantages as drastic experimental conditions, color 
instability and a meticulous control of experimental 
variables (Table 1). 
Organic sulphides are prone to easy oxidation to 
form sulphoxides (R2SO) [22]. The presence of the 
heterocyclic sulphur atom in OLP makes it suscep-
tible to oxidation by iodate which in recent years has 
widely been used in the analysis of pharmaceutical 
substances such as clindamycin [23], novalgin [24], 
ascorbic acid [25], primaquine phosphate [26], famo-
tidine [27], captopril [28], ranitidine [29], methdilazine 
[30] and phenothiazines [31] to name a few. In the 
present method, OLP was oxidized to its sulphoxide 
by iodate in H2SO4 medium and the iodine released 
was used to convert the blue colored nile blue to a 
yellow product (λmax = 400 nm). The absorbance at 
400 nm was found to be linearly dependent on the 
OLP concentration which served as the basis of 
quantification of the drug. The method was found to 
possess the adequate accuracy and precision, sen-
sitivity and selectivity to determine OLP in tablets. 
Table 1. Performance characteristic of the existing spectrophotometric methods and the proposed method 
Sl. No.  Reagents used  Methodology 
λmax 
nm 
Linear range 
µg ml
-1 
LOQ 
µg ml
-1 Remarks Ref. 
1  Hexacyano ferrate (III)  Unreacted oxidant 
measured 
425 2.5-40.0  -  Reaction requires 1:1 mixture of 
H2SO4 and H3PO4, FIA 
assembly required 
19 
  Hexacyano ferrate (III)  Radical cation 
measured 
540  0.5-250    Contact time 60 min required   
  Cerium (IV) sulphate  -do-  540  0.05-300    -do-   
2 NBS  Radical cation 
measured 
532 10-120 
(ε = 4.2×10
4 l mol
-1 cm
-1) 
7.0  Uses 1:1 mixture of H2SO4 and 
H3PO4 as the reaction medium, 
color stable for only 30 S. 
20 
 NBS-Celestine  blue  Unbleached dye 
color measured 
538 0.5-6.0 
(ε = 6.4×10
4 l mol
-1 cm
-1) 
0.30  High acidic conditions required  
  Cerium(IV)-Celestine 
blue 
-do- -do-  0.6-3.0 
(ε = 1.5×10
5 l mol
-1 cm
-1) 
0.37    
3 KIO3  Initial rate of 
formation of radical 
cation measured 
537 0.4-7.0    Scrupulous control of 
experimental variables and 
special equipment for kinetic 
measurement required. 
21 
 KIO3  Maximum 
absorbance 
measured 
537 0.4-7.0       
4 KIO3-Nile blue  Colored product 
formed between I2 
and dye measured 
400 15-120 
(ε = 0.66×10
3 l mol
-1 cm
-1)
11.90 Wide linear dynamic range, 
moderate sensitivity and high 
accuracy and precision 
Present 
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EXPERIMENTAL 
Apparatus 
A Systronic model 106 digital spectrophotometer 
equipped with 1-cm matched quartz cells was used 
for absorbance measurements. 
Reagents and standards 
All chemicals used were of analytical reagent 
grade and distilled water was used to prepare the 
solutions. 
Potassium iodate (5%) was prepared by dissol-
ving 12.5 g of the chemical (Qualigens Fine Chemi-
cals, Mumbai, India) in water and diluted to volume in 
a 250 ml calibrated flask. A stock solution equivalent 
to 1000 µg ml
-1 Nile blue was prepared by dissolving 
111 mg of the dye (Loba Chemie, Mumbai, India, dye 
content: 90%) in alcohol and diluting to the mark with 
the same solvent in a 100 ml standard flask. The 
stock solution was then diluted appropriately with wa-
ter to obtain a working concentration of 100 µg ml
-1. 
Sulphuric acid (0.1 and 2 M) was prepared by diluting 
the appropriately concentrated acid (Merck, Mumbai, 
India, Sp. gr. 1.81) with water. 
Standard solution of olanzapine 
Pharmaceutical grade OLP certified to be 99.85% 
pure was obtained as a gift from Cipla India Ltd., 
Mumbai, India, and used as received. A stock stan-
dard solution equivalent to 1000 µg ml
-1 OLP was 
prepared by dissolving 100 mg of pure drug in 0.1 M 
H2SO4 and diluting to the mark with the same acid in a 
100 ml calibrated flask. The solution was diluted to 
obtain 300 µg ml
-1 OLP with the same acid. 
General procedure 
Different aliquots (0.0, 1.0, 2.0, 3.0 and 4.0 ml) 
of the standard 300 µg ml
-1 OLP solution were mea-
sured accurately and transferred into a series of 10 ml 
calibrated flasks and the total volume was adjusted to 
4 ml with 0.1 M H2SO4. Two ml of 2 M H2SO4 and 1 ml 
of 5% KIO3 were added and the content was mixed 
and let stand for 15 min with occasional shaking. Fi-
nally, 0.5 ml of 100 µg ml
-1 Nile blue was added to 
each flask and diluted to the mark with water and mix-
ed well. The absorbance of the resulting solution was 
measured at 400 nm against the reagent blank. 
A calibration curve was prepared by plotting the 
measured absorbance vs. concentration of OLP, and 
the concentration of the unknown was read from the 
calibration graph or deduced from the regression 
equation derived using the Beer’s law data. 
Procedure for tablets 
Twenty to forty tablets (depending on the num-
ber of mg per tablet) were weighed accurately and 
ground into a fine powder. A quantity of the powder 
containing 100 mg of OLP was accurately weighed 
into a 100 ml calibrated flask and 60 ml of 0.1 M 
H2SO4 was added. The content was shaken for about 
20 min to extract the drug into the liquid phase; the 
volume was finally diluted to the mark with the same 
acid; mixed well and filtered using a Whatman No. 42 
filter paper. First 10 ml portion of the filtrate was dis-
carded, and the subsequent portion was appropriately 
diluted with 0.1 M H2SO4 to obtain a working concen-
tration of 300 µg ml
-1 OLP and the assay completed 
according to the procedure described earlier. 
Method validation procedures 
Linear range and sensitivity 
A pure drug solution in the concentration range 
15-120 µg ml
-1 was treated as described under the 
“General procedure” and the resulting yellow color 
was measured at 400 nm vs. reagent blank to deter-
mine the linear range of applicability. 
Selectivity 
In order to determine the selectivity of the me-
thod, a placebo blank consisting of starch (20 mg), 
sodium alginate (15 mg), lactose (10 mg), methyl cel-
lulose (20 mg), talc (10 mg), acacia (15 mg) and mag-
nesium stearate (10 mg) was prepared, extracted with 
0.1 M H2SO4 and the extract was subjected to ana-
lysis by applying the procedure described earlier. To 
further investigate the influence of the tablet excipi-
ents on the assay of OLP, a synthetic mixture was 
prepared separately by adding 20 mg of OLP to the 
placebo blank cited above, and the steps involved in 
the tablet assay were repeated. 
Assay of precision and accuracy 
To evaluate the method for its precision and ac-
curacy, three different concentrations of OLP were 
analyzed in seven replicates during the same day (in-
tra-day) and on five consecutive days (inter-day). The 
results of this study are presented in Table 3. 
Robustness and ruggedness 
To determine the robustness, two experimental 
variables, the acid concentration and the reaction 
time, were altered deliberately in small increments. 
The method ruggedness was determined by having 
four analysts to perform the assay, and also a single 
analyst doing analysis on three different instruments. 
Application to analysis of tablets 
The method was applied to the determination of 
OLP in three brands of tablets containing different 
amounts (mg), and the results are summarized Table 4. K. BASAVAIAH et al.: IODIMETRIC ASSAY OF OLANZAPINE…  CI&CEQ 15 (2) 95−102 (2009) 
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Recovery study 
A pre-analyzed tablet powder was spiked with 
pure OLP at three different concentration levels (50, 
100 and 150% of that in the tablet powder) and the 
total concentration was found by the proposed me-
thod. Each determination was repeated three times. 
RESULTS AND DISCUSSION 
The proposed method is based on the oxidation 
of OLP by an unmeasured excess of iodate and the 
resulting iodine (the reduced form of iodate) was used 
to iodinate the dye, Nile blue. The yellow colored iodi-
nated dye was measured at 400 nm (Fig. 2) and re-
lated to OLP concentration. The possible reaction 
scheme is given in Fig. 3. 
The various experimental parameters affecting 
the formation of the yellow colored product were opti-
mized and used throughout the experiment. 
Optimization of variables 
The optimum conditions of the proposed method 
responsible for the oxidation of OLP and the forma-
tion of the yellow product were studied and maintain-
ed throughout the experiment. 
product
Blank
 
Fig. 2. Absorption spectra of both the product and blank. 
 
Fig. 3. Tentative reaction scheme. K. BASAVAIAH et al.: IODIMETRIC ASSAY OF OLANZAPINE…  CI&CEQ 15 (2) 95−102 (2009) 
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Effect of acid 
Sulphuric acid was found ideally suited for the 
oxidation of OLP, as well as the conversion of blue 
Nile blue to the yellow product. The absorbance value 
was unaffected when 0.8-1.2 M H2SO4 was main-
tained. Higher concentrations yielded less sensitivity. 
Hence, 2 ml of 2 M H2SO4 was used for both steps of 
the reaction. 
Effect of time 
The effect of time on the oxidation of OLP by io-
date and the formation of yellow color product were 
studied. The reaction between OLP and iodate was 
complete in 15 min as indicated by the discharge of 
purple color of the radical cation [20] and the reaction 
between liberated I2 and Nile blue is found to be in-
stantaneous, and constant absorbance readings were 
obtained when the reaction time was varied from 0-30 
min. The developed yellow color was stable for 30 min. 
Effect of iodate concentration 
To study the effect of iodate concentration, the 
change in the absorbance due to varying concentra-
tions of iodate on fixed concentrations of OLP and 
Nile blue was measured against the respective re-
agent blank. The absorbance values were found to be 
constant in the range of 1-3 ml of 5% KIO3 in a total 
volume of 10 ml; after which further increase in the 
concentration of iodate showed a decreasing trend in 
absorbance (Fig. 4). Therefore, 1 ml of 5% KIO3 in a 
total volume of 10 ml was recommended for the deter-
mination procedure. 
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Fig. 4. Effect of iodate concentration (90 µg mL
-1 OLP). 
Effect of nile blue concentration 
The effect of the Nile blue concentration on the 
formation of yellow the color product was investigated 
in the range of (0.25-1.25 ml) of 0.01% Nile blue. The 
maximum absorbance value was obtained with 0.5 ml 
0.01% Nile blue and no change in the absorbance va-
lue up to 1.25 ml (Fig. 5). Thus, the 0.5 ml of 0.01% 
Nile blue was found to be the most suitable concen-
tration for the determination. 
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Fig. 5. Effect of Nile blue concentration (90 µg mL
-1 OLP). 
Method validation 
Linearity and sensitivity 
The relationship between the absorbance and 
OLP concentration was studied under the optimum 
conditions established. A linear calibration graph was 
obtained in the range 15-120 µg ml
-1 (Table 2). The 
regression analysis of the plot using the method of 
least squares was made to evaluate the intercept (a), 
slope (b), regression coefficient (r) and standard de-
viations of the slope and intercept. The high value of 
the regression coefficient (close to unity) of the re-
gression equation and the negligible value of the in-
tercept (0.005) corroborate the linearity of the calibra-
tion plot. The moderately high sensitivity of the me-
thod was indicated by the fairly high value of molar 
absorptivity and low values of Sandell sensitivity, LOD 
and LOQ. These data are summarized in Table 2. 
Table 2. Analytical and regression parameters 
Parameter Value 
λnm, nm  400 
Beer’s law limits, µg ml
-1   15-120 
Molar absorptivity, L mol
-1cm
-1  0.66×10
3 
Sandel sensitivity, µg cm
-2  0.475 
Limit of detection (LOD), µg ml
-1  3.93 
Limit of quantification (LOQ), µg ml
-1  11.90 
Regression equation, y* 
Intercept (a) 0.005 
Slope (b) 0.002 
Correlation coefficient (r) 0.997 
Standard deviation of the intercept, Sa  0.02098 
Standard deviation of the slope, Sb  0.00022 
*y = a + bx, where y is the absorbance and x is the concentration in µg ml
-1 
The validation of the regression line and the cor-
relation coefficient was further ascertained by back 
calculating the “theoretical” concentrations from the K. BASAVAIAH et al.: IODIMETRIC ASSAY OF OLANZAPINE…  CI&CEQ 15 (2) 95−102 (2009) 
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regression line and comparing them with the original 
concentration values. The calculated percent resi-
duals (RE, %) were in the range of ±2 to ±5 %. The 
results are shown in Table 3 and demonstrate that the 
method provides good accuracy and linearity in the 
given range of concentrations. 
Table 3. The results of validation of the regression line 
OLP taken, µg ml
-1  OLP found, µg ml
-1  RE, % 
60 58.3  2.83 
90 87.5  2.78 
120 122.5 2.08 
Selectivity 
The recommended procedure was applied to the 
analysis of placebo blank and to determine OLP in a 
synthetic mixture. The absorbance of the placebo blank 
extract was nearly the same as that of the reagent 
blank. The results (Table 4) showed that the Stu-
dent’s t and F-values at 95% confidence level were 
less than the theoretical values, which confirmed that 
there is no significant difference between the placebo 
blank absorbance and reagent blank absorbance. In 
order to study the ability of the method to determine 
the analyte in the presence of matrix, the method was 
applied to the synthetic mixture. It was confirmed that 
the change in signal measured (absorbance) was 
caused only by the analyte. The results of the study 
are presented in Table 5 indicating that the common 
tablet excipients did not interfere in the assay. In ad-
dition, the slope of the calibration plot obtained from 
the synthetic mixture solution and pure OLP solution 
were not significantly different. From the calibration 
plot obtained from the synthetic mixture solution, the 
value of the parameters like slope (0.0019), intercept 
(0.005), standard deviation of slope (0.021) and stan-
dard deviation of intercept (0.00024) are almost equal 
to those obtained from the pure drug. 
Assay of precision and accuracy 
The precision of the method was calculated in 
terms of the intermediate precision (intra-day and in-
ter-day). The RSD values of intra-day and inter-day 
studies showed that the precision was good (Table 6). 
The accuracy of an analytical method expresses the 
closeness between the reference value and found va-
lue. Accuracy was evaluated as a percentage relative 
error between the measured concentrations and taken 
concentrations for OLP (bias %). The results obtained 
are compiled in Table 6 and show that the accuracy is 
good. 
Table 4.  Statistical comparison for the absorbance values of 
placebo blank and reagent blank 
Parameter  Placebo blank  Reagent blank 
Mean
a 0.069  0.067 
RE,% 2.98  – 
SD
a  0.003 0.0048 
RSD
a  0.043 0.072 
Variance
a  0.000009 0.000023 
95% CL
b  0.069 ± 0.0037  0.067 ± 0.0059 
F-value
c  2.56  – 
Student’s t-value
c 0.79  – 
aMean of five independent analytes; 
bconfidence limit; 
ctabulated t and 
F-values at 95% confidence level for 4 degrees of freedom are 2.77 and 
6.39, respectively 
Table 5. Recovery of the drug from synthetic mixture 
OLP in synthetic mixture 
taken, µg mL
-1 
OLP recovered
*  ± SD  RE, % 
60 
90 
120 
98.01 ± 1.87 
102.6 ± 1.62 
97.21 ± 1.56 
2.12
1.81
1.43 
*Mean value of five determinations 
Robustness and ruggedness 
In the robustness study, the intermediate preci-
sion expressed as RSD was calculated and found to 
be less than 2.8%. The method ruggedness was ex-
pressed as inter-instruments and inter-analysts preci-
sion. RSD values in both the instances were less than 
3% indicating the acceptable ruggedness. 
Application to analysis of tablets 
The proposed method was successfully applied 
to the determination of OLP in three brands of tablets 
and the results are summarized Table 7. The results 
obtained were statistically compared with those of the 
reference method [17] by applying the Student’s t-test 
for accuracy and F-test for precision. The reference 
method involved the titration of the acetous solution of 
Table 6. Intra-day and inter-day accuracy and precision 
OLP taken, µg ml
-1  Intra-day accuracy and precision (n = 7)  Inter-day accuracy and precision (n = 5) 
OLP found, µg ml
-1  RE, %  RSD, %  OLP found, µg ml
-1  RE, %  RSD, % 
30 30.56  1.87  1.72  30.7  2.33  2.52 
60 60.85  1.42  1.64  61.28  2.14  2.46 
90 90.77  0.86  1.28  91.84  2.04  2.26 K. BASAVAIAH et al.: IODIMETRIC ASSAY OF OLANZAPINE…  CI&CEQ 15 (2) 95−102 (2009) 
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the sample with perchloric acid in acetic acid medium. 
As it can be seen from the Table 6, the calculated 
t-value and F-value at 95% confidence level did not 
exceed the tabulated values of 2.77 and 6.39 respec-
tively, for four degrees of freedom. The tests indicate 
that there is no difference between the proposed me-
thod and the reference method with respect to accu-
racy and precision. 
Recovery study 
To further assess the accuracy and reliability of 
the method, recovery experiments were performed by 
applying the standard-addition technique. The reco-
very was assessed by determining the agreement be-
tween the measured standard concentration and ad-
ded known concentration to the sample [32-34]. The 
recovery values ranged between 97.64 and 103.5% 
with a relative standard deviation <3%. The results of 
this study indicated that the recovery was good and 
that the co-formulated substances did not interfere in 
the determination. 
CONCLUSIONS 
A simple, rapid and cost effective spectrophoto-
metric method was developed and validated for the 
determination of olanzapine. Statistical analysis for 
the results of assay reveals that the method is re-
peatable and selective for the analysis of the active 
ingredient and in tablet formulations without interfe-
rence from excipients. Though the method is less 
sensitive, it presents some advantages over the exist-
ing spectrophotometric methods. The method em-
ploys milder acidic conditions unlike the methods of 
Jasinska and Nalewajko [19] and Krebs et al. [20]. 
The method is faster than the previously reported 
method [19] which requires a contact time of 60 min. 
The present method is based on the measurement of 
a stable colored species unlike the method of Krebs 
et al. [20] where the purple colored radical cation is 
reported to be stable for 30 s only. The kinetic me-
thods using KIO3 as the reagent [21] are prone to give 
inaccurate and imprecise results even under very 
slightly altered conditions of temperature, acid con-
centrations and ionic strength whereas the present 
method has been demonstrated to be both robust and 
rugged. The method employs a less expensive and 
simple instrument compared to the flow injection [19], 
HPLC [13,14], voltammetric [17,18] and capillary zone 
electrophoresis [13] techniques. The method has been 
demonstrated to be more sensitive relative to the re-
ported HPLC [14] method besides enjoying better ac-
curacy and precision compared to the reported spec-
trophotometric and voltammetric methods [13]. The 
method was found to be quite useful to the determi-
nation of olanzapine in the concentration range in which 
the response is linear. 
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